Top Markets
Coin of the day
AzurRx BioPharma, Inc. AzurRx BioPharma, Inc.

AzurRx BioPharma, Inc.

AZRX
Pozycja w akcjach #35193
AzurRx BioPharma, Inc., a Brooklyn, New York-based company employing 12... AzurRx BioPharma, Inc., a Brooklyn, New York-based company employing 12 full-time individuals, focuses on the discovery and advancement of non-systemic biological treatments for various gastrointestinal conditions. Its current developmental portfolio comprises two therapeutic protein assets: MS1819 and AZX1101. MS1819 is an acid-stable lipase enzyme (LIP2), originating from Yarrowia lipolytica, which AzurRx is genetically engineering to address exocrine pancreatic insufficiency (EPI). EPI is a debilitating disorder often seen in patients with chronic pancreatitis (CP) and cystic fibrosis (CF). The second promising compound, AZX1101, is a recombinant beta-lactamase combination sourced from bacteria. This asset is being engineered with a dual aim: to avert nosocomial infections caused by resistant bacterial strains, especially after intravenous beta-lactam antibiotic administration, and to mitigate antibiotic-associated diarrhea (AAD).
Cena akcji
$3.45
Ostatnia synchronizacja: 2021-09-21
Kapitalizacja rynkowa
$4.29M
Zmiana (1 dzień)
2.07%
Zmiana (1 rok)
0.00%
Kraj
US
Handel AzurRx BioPharma, Inc. (AZRX)

Kategoria

Historia ceny akcji dla AzurRx BioPharma, Inc. (AZRX)
Najwyższa cena zamknięcia: $5.04 dnia 2021-09-01

Najniższa cena zamknięcia: $50.52 dnia 2016-10-01
Historia cen akcji firmy AzurRx BioPharma, Inc. od 2016 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2021 -37.15%
2020 -9.98%
2019 -42.81%
2018 -49.10%
2017 -28.62%
2016 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE